YOHENA HERNANDEZ-CLEMENTE: Open Payments
NPI 1780375154 · BELLEVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,178 in 88 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $382 · 2025 $2,178
Food & beverage: $2,089Education: $89
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $442 |
| Regeneron Healthcare Solutions, Inc. | 7 | $252 |
| CSL Behring | 6 | $187 |
| GENZYME CORPORATION | 8 | $182 |
| Novartis Pharmaceuticals Corporation | 6 | $179 |
| Greer Laboratories, Inc. | 7 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $148 |
| Amgen Inc. | 6 | $129 |
| Pharming Healthcare, Inc. | 6 | $113 |
| GlaxoSmithKline, LLC. | 4 | $95 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, ORALAIR, Andembry, RUCONEST, XOLAIR, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
